跳至主要内容
临床试验/jRCT1030240168
jRCT1030240168招募中不适用

Real world Evidence of effectiveness of house dust Mite sublingual Immunotherapy Tablets treatment in patients with allergic rhinitis

Torii Pharmaceutical Co., Ltd.0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
0age over 至 74age old under(—)
性别
All

入选标准

  • At least two 6-SQ HDM SLIT-tablets (10,000 JAU) prescriptions during the first FU year
  • Continuous enrollment (no gaps in insurance time-defined by days) for 12 months before the index event (in the pre-index period)
  • Continuous enrollment (no gaps in insurance time-defined by days) for at least 12 months after the index event (in the post-index period)
  • For the control cohort, the same inclusion criteria will apply, with the exception of inclusion criterion 1.

排除标准

  • Other AIT without JCP SLIT tablets/drops prescription and prescriptions of any biologics 12 months before the index event (in the pre-index period)

研究者

相似试验